These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 5050852)
41. [Inhibitors and stimulators of formation of urinary calculi and their role in the etiology of calcium urolithiasis]. Głuszek J; Pupek-Musialik D; Raszeja-Wanic B Pol Arch Med Wewn; 1980 Oct; 64(4):355-61. PubMed ID: 7454598 [No Abstract] [Full Text] [Related]
42. Calcium oxalate renal stones. Prien EL Annu Rev Med; 1975; 26():173-9. PubMed ID: 1096755 [No Abstract] [Full Text] [Related]
44. Effect of magnesium and pyridoxine supplementation on glycolate induced hyperoxaluria in male albino rats. Gulati S; Narula R; Sadhna S; Sidhu H; Wangoo D; Thind SK; Nath R Indian J Exp Biol; 1988 Jul; 26(7):525-7. PubMed ID: 3198153 [No Abstract] [Full Text] [Related]
45. [Grouping of urinary stones and exactness of analyses (author's transl)]. Gebhardt M; Bastian HP Urol Int; 1976; 31(3):217-9. PubMed ID: 960303 [TBL] [Abstract][Full Text] [Related]
46. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis]. Leskovar P Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987 [TBL] [Abstract][Full Text] [Related]
47. Management of the stone former. Burns JR; Finlayson B Semin Urol; 1984 Feb; 2(1):34-44. PubMed ID: 6463460 [No Abstract] [Full Text] [Related]
51. Prophylaxis of oxalate urolithiasis with alkaline citrates. Frang D; Berényi M; Szebeni R Ther Hung; 1990; 38(2):64-70. PubMed ID: 2377983 [TBL] [Abstract][Full Text] [Related]
52. [A new drug (Magurlyt) in the treatment of urinary calculi]. Frang D; Berényi M; Babics A Orv Hetil; 1974 Jan; 115(4):196-8. PubMed ID: 4839799 [No Abstract] [Full Text] [Related]
53. [Calcium oxalate calculus: therapy and prevention]. Lutzeyer W Dtsch Med Wochenschr; 1969 Jan; 94(3):141. PubMed ID: 5782577 [No Abstract] [Full Text] [Related]
54. Magurlit, a new drug in the treatment of urinary calculus. Frang D; Berényi M; Babics A Ther Hung; 1977; 25(1):27-8. PubMed ID: 854868 [No Abstract] [Full Text] [Related]
55. Treatment of cystinuria and cystine stone disease. Earll JM; Kolb FO Mod Treat; 1967 May; 4(3):539-52. PubMed ID: 6045807 [No Abstract] [Full Text] [Related]
56. [The care of patients with urate calculi]. Szendröi Z Z Urol Nephrol; 1979 May; 72(5):359-63. PubMed ID: 39392 [TBL] [Abstract][Full Text] [Related]
57. [Administration of a diphosphonate in urinary calculi prevention]. Baumann JM; Ganz U; Bisaz S; Fleisch H; Rutishauser G Helv Chir Acta; 1974 Sep; 41(4):421-4. PubMed ID: 4369478 [No Abstract] [Full Text] [Related]
58. Transition of amorphous magnesium ammonium phosphate to a crystalline state in rat urinary calculi induced by L-forms of Proteus mirabilis. Rottschaefer BL; Sax M; Pletcher J Calcif Tissue Res; 1970; 5(1):80-4. PubMed ID: 5470461 [No Abstract] [Full Text] [Related]
59. [Cystine lithiasis and its treatment with d-penicillamine. The experience in a nephrology service in a 23-year period. Apropos of 26 patients]. Combe C; Deforges-Lasseur C; Chehab Z; de Précigout V; Aparicio M Ann Urol (Paris); 1993; 27(2):79-83. PubMed ID: 8503655 [TBL] [Abstract][Full Text] [Related]
60. [At what stage is the dissolution treatment of urinary calculi?]. Steg A; Thomas J Rev Med Suisse Romande; 1980 Nov; 100(11):925-6. PubMed ID: 7466066 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]